Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Analyst Blog: Archive
Altair (ALTR) Buys Cambridge Semantics, Enhances AI Technology (Revised)
by Zacks Equity Research
Altair (ALTR) benefits from strategic acquisitions, solid investments in engineering artificial intelligence and rising demand for its differentiative products.
ALTRNegative Net Change WLDNPositive Net Change STRLNegative Net Change MPTINegative Net Change
construction
Should You Stay Away From Comcast (CMCSA) Ahead of Q1 Earnings?
by Zacks Equity Research
Comcast's (CMCSA) first-quarter 2024 results are expected to reflect a slowing broadband subscriber base, offset by a steady performance of theme parks and the Peacock streaming service.
CMCSAPositive Net Change NFLXNegative Net Change DISNegative Net Change DKNGNegative Net Change
tech-stocks
South Plains Financial (SPFI) Announces 7.7% Dividend Hike
by Zacks Equity Research
South Plains Financial (SPFI) hikes quarterly cash dividend by 7.7% to 14 cents per share. A solid balance sheet and decent liquidity are likely to sustain the company's capital distribution plans.
HONEPositive Net Change OZKNo Net Change SPFIPositive Net Change
finance
Here's How to Play Xcel Energy (XEL) Ahead of Q1 Earnings
by Zacks Equity Research
Xcel Energy's (XEL) first-quarter 2024 earnings are expected to bear the brunt of higher expenses despite an expected increase in customer volume.
EXCPositive Net Change PPLPositive Net Change XELPositive Net Change ETRPositive Net Change
utilities
How to Play VeriSign (VRSN) Ahead of Q1 Earnings Release
by Zacks Equity Research
VeriSign's (VRSN) Q1 performance is likely to have gained from the expansion of its critical infrastructure and services. Soft domain name growth owing to declining demand from China is a concern.
VRSNPositive Net Change SEICPositive Net Change IMAXPositive Net Change METANegative Net Change
tech-stocks
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
by Zacks Equity Research
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports first-quarter 2024 earnings.
MRKPositive Net Change MRNAPositive Net Change NVAXNegative Net Change FATENegative Net Change
pharmaceuticals
Will Cincinnati Financial (CINF) Beat Estimates in Q1 Earnings?
by Zacks Equity Research
Cincinnati Financial's (CINF) first-quarter results are likely to reflect the impact of growth initiatives, increased exposure, better pricing and increased property casualty agency, offset by cat loss.
CINFPositive Net Change KMPRPositive Net Change KNSLPositive Net Change SKWDNegative Net Change
earnings insurance
3 "Magnificent 7" Stock Earnings Coming Up: What to Expect
by Zacks Equity Research
Here, we discuss three companies from the Magnificent Seven - Meta Platforms, Microsoft and Alphabet - that are set to release earnings this week.
MSFTNegative Net Change NVDAPositive Net Change TSLANegative Net Change GOOGLPositive Net Change METANegative Net Change
fang
Nasdaq (NDAQ) Set to Report Q1 Earnings: What to Expect
by Zacks Equity Research
Nasdaq's (NDAQ) first-quarter performance is likely to have been driven by organic revenue growth, and strong Market Platforms businesses, data and listing service revenues and Adenza contributions.
NDAQPositive Net Change CBOEPositive Net Change MKTXNegative Net Change COINPositive Net Change
finance
What's in Store for These 5 Transportation Stocks in Q1 Earnings?
by Maharathi Basu
Let's focus on transportation stocks like UPS, NSC, UNP, LUV and AAL, which are scheduled to release first-quarter 2024 earnings shortly.
LUVPositive Net Change UNPPositive Net Change NSCPositive Net Change UPSPositive Net Change AALPositive Net Change
airlines transportation
Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
by Zacks Equity Research
STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.
STEPositive Net Change PODDNegative Net Change INSPNegative Net Change TMDXPositive Net Change
earnings medical
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
by Zacks Equity Research
Alkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
ALKSPositive Net Change LGNDNegative Net Change ANIPPositive Net Change ADMAPositive Net Change
biotechs
Here's How Atlassian (TEAM) is Poised Ahead of Q3 Earnings
by Zacks Equity Research
Atlassian's (TEAM) Q3 fiscal 2024 results are likely to benefit from the rising adoption of cloud-based solutions, along with the enhancement of its portfolio through AI implementation and buyouts.
CACIPositive Net Change TEAMPositive Net Change VRTPositive Net Change METANegative Net Change
tech-stocks
Auto Roundup: GPC's Quarterly Results, GPI's Buyout Deal of $439M & More
by Rimmi Singhi
While Genuine Parts (GPC) tops earnings estimates and lifts the 2024 adjusted EPS view, Group 1 (GPI) is set to acquire Inchcape's UK operations for $439 million.
FPositive Net Change GPCPositive Net Change NSANYPositive Net Change GPIPositive Net Change TSLANegative Net Change
auto-tires-trucks electric-vehicles
O'Reilly (ORLY) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
The Zacks Consensus Estimate for O'Reilly's (ORLY) first-quarter earnings per share and revenues is pegged at $9.18 and $3.96 billion, respectively.
PCARPositive Net Change ORLYNegative Net Change VCNegative Net Change OSKPositive Net Change
auto-tires-trucks earnings
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
by Zacks Equity Research
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
GILDPositive Net Change ONCYNo Net Change FATENegative Net Change OMGAPositive Net Change
biotechnology biotechs medical pharmaceuticals
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
by Zacks Equity Research
Investors are likely to focus on Opdivo's demand, along with an incremental contribution from newer drugs, when Bristol-Myers (BMY) posts Q1 results.
BMYPositive Net Change ONCYNo Net Change FATENegative Net Change OMGAPositive Net Change
biotechnology biotechs earnings pharmaceuticals
Will Rise in Retail Sales Aid General Motors' (GM) Q1 Earnings?
by Zacks Equity Research
The Zacks Consensus Estimate for General Motors' (GM) first-quarter earnings and revenues is pegged at $2.06 per share and $40.61 billion, respectively.
PCARPositive Net Change GMPositive Net Change VCNegative Net Change OSKPositive Net Change
auto-tires-trucks earnings
Should You Buy Encompass Health (EHC) Ahead of Q1 Earnings?
by Zacks Equity Research
Encompass Health's (EHC) Q1 results are likely to benefit on the back of growing patient volumes and commendable expansion initiatives.
HCAPositive Net Change PODDNegative Net Change LNTHNegative Net Change EHCPositive Net Change
earnings medical
Otis Worldwide (OTIS) to Post Q1 Earnings: Factors to Note
by Zacks Equity Research
Otis Worldwide's (OTIS) first-quarter 2024 performance is likely to have benefited from strong volume and favorable pricing. Yet, currency fluctuations are a concern.
DYPositive Net Change WLDNPositive Net Change OTISPositive Net Change DFHPositive Net Change
construction earnings
J. B. Hunt (JBHT) Hurt by Segmental Weakness, High Debt
by Zacks Equity Research
Lower revenues across majority of its business segments, higher net interest expense, and a highly leveraged balance sheet weigh on J. B. Hunt's (JBHT) results.
JBHTPositive Net Change ALPositive Net Change KEXPositive Net Change
transportation
Should Investors Buy EMCOR (EME) Ahead of Q1 Earnings?
by Zacks Equity Research
EMCOR's (EME) first-quarter 2024 performance is likely to have benefited from increased project flow and strength in the combined U.S. Construction segments and the U.S. Building Services segment.
EMEPositive Net Change DYPositive Net Change WLDNPositive Net Change DFHPositive Net Change
construction earnings
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Investor focus is likely to be on the sales of AbbVie's (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports first-quarter results.
SRPTNegative Net Change ABBVPositive Net Change CTMXPositive Net Change LABPNegative Net Change
biotechs medical pharmaceuticals
What Should You Do With Teradyne (TER) Ahead of Q1 Earnings
by Zacks Equity Research
Teradyne's (TER) first-quarter 2024 top line is likely to have benefited from its robust and diversified portfolio despite the weak Robotics and HDD market.
TERPositive Net Change MSCIPositive Net Change VRTPositive Net Change METANegative Net Change
earnings tech-stocks
McCormick (MKC) Benefits From Strategic Buyouts & Cost Savings
by Zacks Equity Research
McCormick's (MKC) commitment to achieving long-term objectives is evident from its proven track record, wide-reaching and competitive global portfolio and focus on high-growth areas.
MKCPositive Net Change CELHNegative Net Change VITLPositive Net Change UTZPositive Net Change
consumer-staples